본문 바로가기
KERD
논문KCI 등재

Distribution pattern and prevalence of West Nile virus infection in Nigeria from 1950 to 2020: a systematic review

Anthony Uchenna Emeribe|Justin Onyebuchi Nwofe|Abubakar Muhammad Gwarzo|Idris Nasir Abdullahi|Peter Elisha Ghamba|Pius Omoruyi Omosigho|Zakariyya Muhammad Bello|Bamidele Soji Oderinde|Samuel Ayobami Fasogbon|Lawal Olayemi|Isa Muhammad Daneji|Muhammad Hamis Musa|Nkechi Blessing Onukegbe|Chukwudi Crescent Okume|Sanusi Musa|Odunayo Oyetola Rahmat Ajagbe
한국역학회 (Korean Society of Epidemiology)|2020.01|Epidemiology and Health|제42권 |pp. 1-11|DOI 10.4178/epih.e2020071

0

조회

0

다운로드

0

인용

0

참고문헌

키워드

NigeriaOne HealthZoonosisWest Nile virusPooled prevalence

초록

OBJECTIVES: West Nile virus (WNV) is a re-emerging mosquito-borne viral infection. This study investigated the pooled prevalence pattern and risk factors of WNV infection among humans and animals in Nigeria. METHODS: A systematic review was conducted of eligible studies published in PubMed, Scopus, Google Scholar, and Web of Science from January 1, 1950 to August 30, 2020. Peer-reviewed cross-sectional studies describing WNV infections in humans and animals were systematically reviewed. Heterogeneity was assessed using the Cochrane Q statistic. RESULTS: Eighteen out of 432 available search output were eligible and included for this study. Of which 13 and 5 were WNV studies on humans and animals, respectively. Although 61.5% of the human studies had a low risk of bias, they all had high heterogeneity. The South West geopolitical zone of Nigeria had the highest pooled prevalence of anti-WNV immunoglobulin M (IgM; 7.8% in humans). The pooled seroprevalence of anti-WNV IgM and immunoglobulin G (IgG) was 7.1% (95% confidence interval [CI], 5.9 to 8.3) and 76.5% (95% CI, 74.0 to 78.8), respectively. The WNV RNA prevalence was 1.9% (95% CI, 1.4 to 2.9), while 14.3% (95% CI, 12.9 to 15.8) had WNV-neutralizing antibodies. In animals, the pooled seroprevalence of anti-WNV IgM and IgG was 90.3% (95% CI, 84.3 to 94.6) and 3.5% (95% CI, 1.9 to 5.8), respectively, while 20.0% (95% CI, 12.9 to 21.4) had WNV-neutralizing antibodies. Age (odds ratio [OR], 3.73; 95% CI, 1.87 to 7.45; p<0.001) and level of education (no formal education: OR, 4.31; 95% CI, 1.08 to 17.2; p<0.05; primary: OR, 7.29; 95% CI, 1.80 to 29.6; p<0.01) were significant risk factors for WNV IgM seropositivity in humans. CONCLUSIONS: The findings of this study highlight the endemicity of WNV in animals and humans in Nigeria and underscore the need for the One Health prevention and control approach.

Abstract

OBJECTIVES: West Nile virus (WNV) is a re-emerging mosquito-borne viral infection. This study investigated the pooled prevalence pattern and risk factors of WNV infection among humans and animals in Nigeria. METHODS: A systematic review was conducted of eligible studies published in PubMed, Scopus, Google Scholar, and Web of Science from January 1, 1950 to August 30, 2020. Peer-reviewed cross-sectional studies describing WNV infections in humans and animals were systematically reviewed. Heterogeneity was assessed using the Cochrane Q statistic. RESULTS: Eighteen out of 432 available search output were eligible and included for this study. Of which 13 and 5 were WNV studies on humans and animals, respectively. Although 61.5% of the human studies had a low risk of bias, they all had high heterogeneity. The South West geopolitical zone of Nigeria had the highest pooled prevalence of anti-WNV immunoglobulin M (IgM; 7.8% in humans). The pooled seroprevalence of anti-WNV IgM and immunoglobulin G (IgG) was 7.1% (95% confidence interval [CI], 5.9 to 8.3) and 76.5% (95% CI, 74.0 to 78.8), respectively. The WNV RNA prevalence was 1.9% (95% CI, 1.4 to 2.9), while 14.3% (95% CI, 12.9 to 15.8) had WNV-neutralizing antibodies. In animals, the pooled seroprevalence of anti-WNV IgM and IgG was 90.3% (95% CI, 84.3 to 94.6) and 3.5% (95% CI, 1.9 to 5.8), respectively, while 20.0% (95% CI, 12.9 to 21.4) had WNV-neutralizing antibodies. Age (odds ratio [OR], 3.73; 95% CI, 1.87 to 7.45; p<0.001) and level of education (no formal education: OR, 4.31; 95% CI, 1.08 to 17.2; p<0.05; primary: OR, 7.29; 95% CI, 1.80 to 29.6; p<0.01) were significant risk factors for WNV IgM seropositivity in humans. CONCLUSIONS: The findings of this study highlight the endemicity of WNV in animals and humans in Nigeria and underscore the need for the One Health prevention and control approach.

참고문헌 (47)

  1. Petersen LR, "West Nile virus : review of the literature", JAMA, 310, pp.308~315 (2013)
  2. Alba A, "Ecological surveillance for West Nile in Catalonia(Spain), learning from a five-year period of follow-up", Zoonoses Public Health, 61, pp.181~191 (2014)
  3. Rizzoli A, "The challenge of West Nile virus in Europe : knowledge gaps and research priorities", Euro Surveill, 20, pp.21135~ (2015)
  4. Bai F, "Current understanding of West Nile virus clinical manifestations, immune responses, neuroinvasion, and immunotherapeutic implications", Pathogens, 8, pp.193~ (2019)
  5. Cahill ME, "Identification of genetic variants associated with dengue or West Nile virus disease : a systematic review and meta-analysis", BMC Infect Dis, 18, pp.282~ (2018)
  6. Kilpatrick AM, "Globalization, land use, and the invasion of West Nile virus", Science, 334, pp.323~327 (2011)
  7. Sule WF, "Epidemiology and ecology of West Nile virus in sub-Saharan Africa", Parasit Vectors, 11, pp.414~ (2018)
  8. "Geography of Nigeria"[URL]
  9. "Nigeria population"[URL]
  10. Oderinde BS, "Prevalence of locally undetected acute infections of Flaviviruses in North-Eastern Nigeria", Virus Res, 286, pp.198060~ (2020)
  11. Motayo BO, "Seasonal abundance and molecular identification of West Nile virus vectors, Culex pipens and Culex quinquefasciatus(diptera : culicidae)in Abeokuta, South-West, Nigeria", Afr Health Sci, 16, pp.135~140 (2016)
  12. Okechukwu CE, "Implications of Flaviviruses cross-reactivity and vaccination programs on their serodiagnosis", N Y Sci J, 10, pp.19~22 (2017)
  13. Liberati A, "The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration", BMJ, 339 (2009)
  14. Humphrey JM, "Dengue in the Middle East and North Africa : a systematic review", PLoS Negl Trop Dis, 10, pp.e0005194~ (2016)
  15. Fincham JE, "Response rates and responsiveness for surveys, standards, and the Journal", Am J Pharm Educ, 72, pp.43~ (2008)
  16. Kelley K, "Good practice in the conduct and reporting of survey research", Int J Qual Health Care, 15, pp.261~266 (2003)
  17. Hatcher EL, "Virus variation resource-improved response to emergent viral outbreaks", Nucleic Acids Res, 45, pp.D482~D490 (2017)
  18. Ma‟aji JA, "Seroprevalence and molecular detection of west Nile virus in febrile patients attending some hospitals in Kaduna state, Nigeria", pp.2017
  19. Macnamara FN, "Yellow fever and other arthropod-borne viruses; a consideration of two serological surveys made in South Western Nigeria", Trans R Soc Trop Med Hyg, 53, pp.202~212 (1959)
  20. Olaleye OD, "A survey for haemagglutination-inhibiting antibody to West Nile virus in human and animal sera in Nigeria", Comp Immunol Microbiol Infect Dis, 13, pp.35~39 (1990)
  21. Baba M, "Evidence of arbovirus co-infection in suspected febrile malaria and typhoid patients in Nigeria", J Infect Dev Ctries, 7, pp.51~59 (2013)
  22. Adesina OA, "Detection of Chikungunya and West Nile viruses in febrile patients in Ile-Ife Osun State, Nigeria using real time reverse transcription-polymerase chain reaction(RT-PCR)", Afr J Microbiol Res, 11, pp.1136~1141 (2017)
  23. Bukbuk DN, "Seroprevalence of neutralizing antibodies to West Nile virus(WNV)among patients with pyrexia of an unknown origin(PUO)in Maiduguri, Borno State, Nigeria", Ann Microbiol Infect Dis, 1, pp.7~11 (2017)
  24. Oladipo EK, "Yellow fever, Dengue fever and West Nile Viruses co-circulation in Ogbomoso", Int J Med Dev Countries, 2(2), pp.50~54 (2018)
  25. Baba MM, "West Nile virus in mosquitoes and febrile patients in a semi-arid zone, Nigeria", J Am Sci, 2, pp.28~34 (2006)
  26. Opaleye OO, "Absence of serological evidence of West Nile virus in blood donors in South Western Nigeria", Sudan J Med Sci, 9, pp.235~238 (2014)
  27. Omilabu SA, "West Nile Complement Fixing antibodies in Nigerian domestic animals and humans", J Hyg Epidemiol Microbiol Immunol, 34, pp.357~363 (1990)
  28. Kolawole OE, "West Nile virus infection in Ogbomoso : serological evidence", J Immunoassay Immunochem, 36, pp.573~578 (2015)
  29. Kolawole OM, "Emergence and associated risk factors of vector borne west nile virus infection in Ilorin, Nigeria", J Arthropod Borne Dis, 12, pp.341~350 (2018)
  30. Baba SS, "Preliminary study on the prevalence of West Nile virus antibody among horses, donkeys and camels in Borno State, Nigeria", J Appl Virol, 3, pp.39~45 (2014)
  31. Sule WF, "West Nile virus antibodies in horse grooms in Lagos and Ibadan, Southwest Nigeria", Alex J Vet Sci, 49, pp.13~17 (2016)
  32. Olaleye OD, "A survey for haemagglutination-inhibiting antibody to West Nile virus in human and animal sera in Nigeria", Comp Immunol Microbiol Infect Dis, 13, pp.35~39 (1990)
  33. Waziri IJ, "Serosurvey of West Nile virus in household-reared pigeons in Bauchi metropolis, Nigeria", Trans R Soc Trop Med Hyg, 112, pp.169~174 (2018)
  34. Omilabu SA, "West Nile Complement Fixing antibodies in Nigerian domestic animals and humans", J Hyg Epidemiol Microbiol Immunol, 34, pp.357~363 (1990)
  35. Zehender G, "Spatial and temporal dynamics of hepatitis B virus D genotype in Europe and the Mediterranean Basin", PLoS One, 7, pp.e37198~ (2012)
  36. Baniasadi V, "An imported case of dengue fever in Iran, 2015", Iran J Virol, 10, pp.31~34 (2016)
  37. Eybpoosh S, "Epidemiology of West Nile Virus in the Eastern Mediterranean region : a systematic review", PLoS Negl Trop Dis, 13, pp.e0007081~ (2019)
  38. Lustig Y, "Surveillance and diagnosis of West Nile Virus in the face of flavivirus cross-reactivity", Front Microbiol, 9, pp.2421~ (2018)
  39. Beck C, "Flaviviruses in Europe : complex circulation patterns and their consequences for the diagnosis and control of West Nile disease", Int J Environ Res Public Health, 10, pp.6049~6083 (2013)
  40. Abdullahi IN, "Prevalence pattern of chikungunya virus infection in Nigeria : a four decade systematic review and meta-analysis", Pathog Glob Health, 114, pp.111~116 (2020)
  41. Tilley PA, "Nucleic acid testing for west Nile virus RNA in plasma enhances rapid diagnosis of acute infection in symptomatic patients", J Infect Dis, 193, pp.1361~1364 (2006)
  42. Macdonald J, "NS1 protein secretion during the acute phase of West Nile virus infection", J Virol, 79, pp.13924~13933 (2005)
  43. Wang W, "Seroprevalence of West Nile virus in Ghana", Viral Immunol, 22, pp.17~22 (2009)
  44. 김경설, "First detection of West Nile virus in domestic pigeon in Korea", Journal of Veterinary Science, 17(4), pp.587~589 (2016), 대한수의학회[DOI]
  45. Komar N, "Serologic evidence for West Nile virus infection in birds in the New York City vicinity during an outbreak in 1999", Emerg Infect Dis, 7, pp.621~625 (2001)
  46. Panella NA, "Experimental infection of Eurasian collared-dove(Streptopelia decaocto)with West Nile virus", J Vector Ecol, 38, pp.210~214 (2013)
  47. Sule WF, "Analysis of Culex and Aedes mosquitoes in southwestern Nigeria revealed no West Nile virus activity", Pan Afr Med J, 23, pp.116~ (2016)

관련 논문AI추천

Dengue Virus is Hyperendemic in Nigeria from 2009 to 2020: A Contemporary Systematic ReviewAbigail Uchenna Emelonye, Abubakar Muhammad Gwarzo, Amos Dangana, Anthony Ogbonna Emeribe, Anthony Uchenna Emeribe, Bibiana Nonye Egenti, Buhari Isa Shuaib, Chikodi Modesta Umeozuru, Hadiza Yahaya, Idongesit Kokoabasi Isong, Idris Nasir Abdullahi, Justin Onyebuchi Nwofe, Madjid Sadi, Maijiddah Saidu Aminu, Mala Alhaji Baba Mallam, Silifat Oyewusi, Yahaya Usman대한감염학회 · Infection and Chemotherapy2021 · 제53권 제2호Prevalence and Genetic Characteristics of Japanese Encephalitis Virus among Mosquitoes and Pigs in Hunan Province, China from 2019 to 2021Deng Zaofu, Ge Lingrui, Song Guo, Tang Qiwu, Tan Shengguo, Zhang Hai한국미생물·생명공학회 · Journal of Microbiology and Biotechnology2022 · 제32권 제9호Knowledge, attitudes, and behavioural risk factors regarding zoonotic infections among bushmeat hunters and traders in Nsukka, southeast NigeriaKingsley Uchenna Ozioko, Raymond Awudu Agbu한국역학회 · Epidemiology and Health2018 · 제40권 NIPAH Virus - “A Bane to Mankind”Krishnasamy Lakshmi, Velmurugan Jaiganeshan Muttiah한국미생물·생명공학회 · 한국미생물·생명공학회지2024 · 제52권 제3호Malaria Endemicity in the Rural Communities of Ebonyi State, NigeriaDavid Ekene Nwele, Ikechukwu Oliver Onyali, Michael Okpara Elom, Milliam Okwudili Iwueze, Ogbonna Elom Sabastian Uguru대한기생충학ㆍ열대의학회 · Parasites, Hosts and Diseases2022 · 제60권 제3호The prevalence of Q fever in the Eastern Mediterranean region: a systematic review and meta-analysisAhmadinezhad Mozhgan, Doostiirani Amin, mounesan leila, Yousefi Behzadi Manijeh한국역학회 · Epidemiology and Health2022 · 제44권

이 간행물의 다른 논문 (73건)

Factors affecting awareness of myocardial infarction symptoms among the general public in Korea박경실pp. 1-7WHO International Health Regulations Emergency Committee for the COVID-19 outbreak지영미pp. 1-13Time-variant reproductive number of COVID-19 in Seoul, Korea김종훈, 박보영, 나백주, 최보율, Seong-Geun Moon, Yeon-Kyung Kim, 손우식, Jungsoon Choipp. 1-5The effects of mental health on recurrent falls among elderly adults, based on Korean Community Health Survey data류소연, 박종, 조경희pp. 1-5An interim review of the epidemiological characteristics of 2019 novel coronavirus천병철, 유석현, Korean Society of Epidemiology 2019-nCoV Task Force Teampp. 1-4
원문 보기